« FDA Approvals - OMRIX Biopharmaceuticals Receives FDA Approval For General Hemostasis In Surgery | Main | FDA Approves Voluven to Treat Serious Blood Volume Loss following »

Noven Receives FDA Warning Letter Related to Mid-2007 Facility Inspection


Noven Receives FDA Warning Letter Related to Mid-2007 Facility Inspection (Centre Daily Times)
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced that yesterday it received a warning letter from the U.S. Food and Drug Administration (FDA) related to a prior on-site inspection of Noven's Miami manufacturing facility.
 

©2006 FDA-News.com. All rights reserved.